comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 14:19:52 - browse：41

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use.

The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.’s second most expensive drug, behind a recently approved gene therapy for hemophilia. CEO Doug Ingram said on a conference call the price was below what a recently published company-funded analysis found would be cost-effective.

“The approval of Elevidys is a watershed moment for the treatment of Duchenne. Elevydis is the first and only gene therapy approved for Duchenne, and this approval brings us closer to our goal of bringing forward a treatment that provides the potential to alter the trajectory of this degenerative disease,” Ingram said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Travis Kelce and the trap of celebrity vaccine endorsements

WSS

Travis Kelce and the trap of celebrity vaccine endorsements

Late stage cancers on the rise after pandemic delayed screenings

It costs an awful lot of money to give away a kidney

Physicians aren't 'burning out.' They're suffering from moral injury

Florida officials tell state schools to teach AP Psychology 'in its entirety'

The cancer stories no one wants to hear

hotspot

comprehensive

hotspot

Activists slam private health insurers over coverage restrictions

Bill would allow buprenorphine prescription for addiction via telehealth

Dobbs anniversary: the lost opportunity of abortion as health care

Medicare must police algorithms in Medicare Advantage, Dems say

Hepatitis C has a cure — but many Americans still lack access to it

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

New air purifier tech could be key to improving indoor air quality

Flint parents haunted by uncertainty, fears of lead poisoning

Medicare details structure of new drug price negotiation program

Chris Christie meets with Zelenskyy during Ukraine trip

hotspot

Bill would allow buprenorphine prescription for addiction via telehealth

Personalized medicine goes far beyond genetics

H.R. 3 is the wrong path to lower drug costs

Life sciences investors close nearly $6 billion in new funds

Travis Kelce and the trap of celebrity vaccine endorsements

Explaining an after

explore

focus

focus

hotspot